Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions - sprookjes - yvandenbroek - TriplyDB

Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions

Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions

http://www.wikidata.org/entity/Q28542607

about

Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control Dengue: an update on treatment options Households as foci for dengue transmission in highly urban Vietnam Galectin-1 exerts inhibitory effects during DENV-1 infection Trends of Dengue Disease Epidemiology.The value of daily platelet counts for predicting dengue shock syndrome: Results from a prospective observational study of 2301 Vietnamese children with dengue.Current Status of Dengue Therapeutics Research and Development.Dengue Knowledge and Preventive Practices in Iquitos, Peru.The potential role of Wolbachia in controlling the transmission of emerging human arboviral infections Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.Investigational drugs in early development for treating dengue infection.Determining the efficacy of guppies and pyriproxyfen (Sumilarv® 2MR) combined with community engagement on dengue vectors in Cambodia: study protocol for a randomized controlled trial.Identification of resveratrol analogs as potent anti-dengue agents using a cell-based assay.Challenges and recent progress in drug discovery for tropical diseases

P2860

Q24261248-D87AB012-2AF3-443B-B848-C665281F3956 Q26314452-05A7B5E4-9FAE-4D4B-B870-C61369972D9E Q28085044-959706C5-E8D7-4AF0-90E8-89B20AEBA4A0 Q28543456-474AC067-6A28-4168-9734-6EDAAD139335 Q28544937-5205B9FD-1B20-4510-831D-B83F89C1466D Q30145525-6825BB8F-DF9E-4B46-9F67-392C6AAD36AC Q33441421-8F50B481-0884-4893-A80D-61FB6C883DE7 Q33552896-46E3EE84-343F-40BF-81B3-BA139D9F3A74 Q36359333-785FCE78-0859-48F1-9249-AFC92170EB6B Q37665028-DE2CD8AB-2ACE-480F-90AC-06E5AF64FC2B Q38697863-F0937619-9ABF-4E67-9EB1-DD49CCD2D28F Q38870485-BB9BC7FB-D6CD-466D-96CB-37474469FD51 Q39089888-984A8FF3-8220-4B74-BFAC-6E4C9AB4795E Q40093351-3288A28F-F5EB-43A4-98BC-D63AAE805529 Q59073293-6E91D229-8455-40FC-ACF8-9B3429388BA5

P2860

Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions

http://www.wikidata.org/entity/Q28542607

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Dengue therapeutics, chemoprop ...... the art and future directions

@ast

Dengue therapeutics, chemoprop ...... the art and future directions

@en

Dengue therapeutics, chemoprop ...... the art and future directions

@nl

type

label

Dengue therapeutics, chemoprop ...... the art and future directions

@ast

Dengue therapeutics, chemoprop ...... the art and future directions

@en

Dengue therapeutics, chemoprop ...... the art and future directions

@nl

prefLabel

Dengue therapeutics, chemoprop ...... the art and future directions

@ast

Dengue therapeutics, chemoprop ...... the art and future directions

@en

Dengue therapeutics, chemoprop ...... the art and future directions

@nl

P1433

Q28542607-D9621D20-3269-4E55-933B-D0130495EF66

P1476

Q28542607-7538549D-289A-45DD-AF41-E06888E2EFE1

P2093

Q28542607-111908CD-4C9D-4C62-A746-2BD74D59CD63

Q28542607-3B72B7F1-5BCB-4C04-90EC-D20E9D462FE9

Q28542607-BC09F031-E446-4D5C-B1B7-A99E3E15CE16

Q28542607-C842673E-EBE3-4F59-B797-A506218AA1F0

Q28542607-C9EB31C9-3CA1-4D62-A6A9-E833E01A1B5D

Q28542607-FFEBA357-29EA-40F4-8EF8-EE9176345F7B

P275

Q28542607-32BA2A72-F7F8-43CC-AC21-B5037ADFA098

P2860

Q28542607-0225CC35-3B81-40C8-90E8-27EDECD09F4A

Q28542607-040DC5E7-73AD-4963-A7DB-4DAE92EB073E

Q28542607-0C83E4A0-6B26-497D-9E63-EFB1A9B91462

Q28542607-0C8A1B8B-5F09-49EA-92F8-84F71A45B6E0

Q28542607-17A7D848-910D-4017-96F5-8E30CF64FF32

Q28542607-1DCD8019-8B82-438E-BAFD-5834E2949FB6

Q28542607-1E50976E-A8AF-4C42-A9AB-83A116A24182

Q28542607-1F683A0E-6094-4DAE-8EA2-7344BEAABA24

Q28542607-2045A95F-99D8-48F0-968D-37506997C317

Q28542607-225905E1-499C-4CF5-9127-F008D78DEC16

P304

Q28542607-A78AC682-129A-42F1-A516-DCDBC2460DE7

P31

Q28542607-44FCC3B5-A144-4AF5-9F4C-879D50E5C1C9

Q28542607-88F5A713-9EAD-417F-A1BC-D66E9F0966C4

P356

Q28542607-6712FF49-4874-4CE7-BE8F-D1827689C556

P407

Q28542607-93D1A863-6A06-45AC-A20C-81AA864349EC

P433

Q28542607-8EB6B1A0-7C84-4109-BBD8-79BF1B61DB4C

P478

Q28542607-ABAE2441-2F4E-4D42-84B4-F2604C6D986F

P50

Q28542607-294DB791-8BA1-467A-8CD7-C388A3C3CCAE

Q28542607-2A4B80E3-6CFF-4A80-9ED4-586208C790A8

Q28542607-51D4AFF3-5A4C-41F2-9877-4A96CF5AC6A0

P5008

Q28542607-0E9CF081-3FE2-4C94-845E-E556815103F3

P577

Q28542607-3A3DACD2-AB93-4ABF-8416-2952D30685A2

Q28542607-E250B9D7-D354-4FE5-9102-6B75D3A388E5

P5875

Q28542607-D2739AA6-1881-4CEE-98FF-E661C2AD723F

P698

Q28542607-0908460A-1485-4189-B388-56C23E329980

P921

Q28542607-2B6746EA-F65D-45EE-992D-B90EDF354339

Q28542607-6CC63EDC-0DD8-4C8C-BE30-3BC87C3C3643

Q28542607-82476B95-E303-46DA-B005-A75F2ABB9E15

Q28542607-F51EF4A1-566F-4452-A687-3CE6F02261DC

P932

Q28542607-44E6A468-6F73-4581-AE23-5F6B427D52B8

P356

JOURNAL.PNTD.0003025

P1433

PLOS Neglected Tropical Diseases

P1476

Dengue therapeutics, chemoprop ...... the art and future directions

@en

P2093

James Whitehorn

http://www.w3.org/2001/XMLSchema#string

Katherine L Anders

http://www.w3.org/2001/XMLSchema#string

Louis R Macareo

http://www.w3.org/2001/XMLSchema#string

M Cristina Cassetti

http://www.w3.org/2001/XMLSchema#string

Sophie Yacoub

http://www.w3.org/2001/XMLSchema#string

Vinh Chau Nguyen Van

http://www.w3.org/2001/XMLSchema#string

P275

P2860

Statins for the primary prevention of cardiovascular disease

The global distribution and burden of dengue

Should hydroxyethyl starch solutions be totally banned?

Randomized, Placebo-Controlled Trial of Nonpegylated and Pegylated Forms of Recombinant Human Alpha Interferon 2a for Suppression of Dengue Virus Viremia in Rhesus Monkeys

An adenosine nucleoside inhibitor of dengue virus

Dengue virus-induced hemorrhage in a nonhuman primate model

Clinical and Virological Features of Dengue in Vietnamese Infants

The structural basis for serotype-specific neutralization of dengue virus by a human antibody

Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis

P304

e3025

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PNTD.0003025

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Cameron P. Simmons

P5008

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265135805

http://www.w3.org/2001/XMLSchema#string

P698

25166493

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

biomedical investigative technique

P932

4148227

http://www.w3.org/2001/XMLSchema#string